The Stanton lab is generating induced pluripotent stem cells (iPSC) from patients with neurodevelopmental disorders. These patient-specific iPSC are converted into neurons and organoids, thus providing an opportunity to understand the molecular pathology of diseases such as autism and establishing a foundation for the development of diagnostics and therapeutics.